Cargando…
P1269: VIP152 IS A NOVEL CDK9 INHIBITOR WITH IMPROVED SELECTIVITY, TARGET MODULATION, AND CARDIAC SAFETY IN PATIENTS WITH LYMPHOMA
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430317/ http://dx.doi.org/10.1097/01.HS9.0000847940.03718.3d |
| _version_ | 1784779733074968576 |
|---|---|
| author | Frigault, M. Sher, S. Ravikrishnan, J. Izumi, R. Ware, J. Wong, H. Johnson, A. Stelte-Ludwig, B. Byrd, J. Sampath, D. Rogers, K. Woyach, J. Lapalombella, R. Hamdy, A. |
| author_facet | Frigault, M. Sher, S. Ravikrishnan, J. Izumi, R. Ware, J. Wong, H. Johnson, A. Stelte-Ludwig, B. Byrd, J. Sampath, D. Rogers, K. Woyach, J. Lapalombella, R. Hamdy, A. |
| author_sort | Frigault, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430317 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94303172022-08-31 P1269: VIP152 IS A NOVEL CDK9 INHIBITOR WITH IMPROVED SELECTIVITY, TARGET MODULATION, AND CARDIAC SAFETY IN PATIENTS WITH LYMPHOMA Frigault, M. Sher, S. Ravikrishnan, J. Izumi, R. Ware, J. Wong, H. Johnson, A. Stelte-Ludwig, B. Byrd, J. Sampath, D. Rogers, K. Woyach, J. Lapalombella, R. Hamdy, A. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430317/ http://dx.doi.org/10.1097/01.HS9.0000847940.03718.3d Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Frigault, M. Sher, S. Ravikrishnan, J. Izumi, R. Ware, J. Wong, H. Johnson, A. Stelte-Ludwig, B. Byrd, J. Sampath, D. Rogers, K. Woyach, J. Lapalombella, R. Hamdy, A. P1269: VIP152 IS A NOVEL CDK9 INHIBITOR WITH IMPROVED SELECTIVITY, TARGET MODULATION, AND CARDIAC SAFETY IN PATIENTS WITH LYMPHOMA |
| title | P1269: VIP152 IS A NOVEL CDK9 INHIBITOR WITH IMPROVED SELECTIVITY, TARGET MODULATION, AND CARDIAC SAFETY IN PATIENTS WITH LYMPHOMA |
| title_full | P1269: VIP152 IS A NOVEL CDK9 INHIBITOR WITH IMPROVED SELECTIVITY, TARGET MODULATION, AND CARDIAC SAFETY IN PATIENTS WITH LYMPHOMA |
| title_fullStr | P1269: VIP152 IS A NOVEL CDK9 INHIBITOR WITH IMPROVED SELECTIVITY, TARGET MODULATION, AND CARDIAC SAFETY IN PATIENTS WITH LYMPHOMA |
| title_full_unstemmed | P1269: VIP152 IS A NOVEL CDK9 INHIBITOR WITH IMPROVED SELECTIVITY, TARGET MODULATION, AND CARDIAC SAFETY IN PATIENTS WITH LYMPHOMA |
| title_short | P1269: VIP152 IS A NOVEL CDK9 INHIBITOR WITH IMPROVED SELECTIVITY, TARGET MODULATION, AND CARDIAC SAFETY IN PATIENTS WITH LYMPHOMA |
| title_sort | p1269: vip152 is a novel cdk9 inhibitor with improved selectivity, target modulation, and cardiac safety in patients with lymphoma |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430317/ http://dx.doi.org/10.1097/01.HS9.0000847940.03718.3d |
| work_keys_str_mv | AT frigaultm p1269vip152isanovelcdk9inhibitorwithimprovedselectivitytargetmodulationandcardiacsafetyinpatientswithlymphoma AT shers p1269vip152isanovelcdk9inhibitorwithimprovedselectivitytargetmodulationandcardiacsafetyinpatientswithlymphoma AT ravikrishnanj p1269vip152isanovelcdk9inhibitorwithimprovedselectivitytargetmodulationandcardiacsafetyinpatientswithlymphoma AT izumir p1269vip152isanovelcdk9inhibitorwithimprovedselectivitytargetmodulationandcardiacsafetyinpatientswithlymphoma AT warej p1269vip152isanovelcdk9inhibitorwithimprovedselectivitytargetmodulationandcardiacsafetyinpatientswithlymphoma AT wongh p1269vip152isanovelcdk9inhibitorwithimprovedselectivitytargetmodulationandcardiacsafetyinpatientswithlymphoma AT johnsona p1269vip152isanovelcdk9inhibitorwithimprovedselectivitytargetmodulationandcardiacsafetyinpatientswithlymphoma AT stelteludwigb p1269vip152isanovelcdk9inhibitorwithimprovedselectivitytargetmodulationandcardiacsafetyinpatientswithlymphoma AT byrdj p1269vip152isanovelcdk9inhibitorwithimprovedselectivitytargetmodulationandcardiacsafetyinpatientswithlymphoma AT sampathd p1269vip152isanovelcdk9inhibitorwithimprovedselectivitytargetmodulationandcardiacsafetyinpatientswithlymphoma AT rogersk p1269vip152isanovelcdk9inhibitorwithimprovedselectivitytargetmodulationandcardiacsafetyinpatientswithlymphoma AT woyachj p1269vip152isanovelcdk9inhibitorwithimprovedselectivitytargetmodulationandcardiacsafetyinpatientswithlymphoma AT lapalombellar p1269vip152isanovelcdk9inhibitorwithimprovedselectivitytargetmodulationandcardiacsafetyinpatientswithlymphoma AT hamdya p1269vip152isanovelcdk9inhibitorwithimprovedselectivitytargetmodulationandcardiacsafetyinpatientswithlymphoma |